Traditionally, FMRP is classified as a cytoplasmic RNA-binding protein and functions as a translational repressor in the metabotropic glutamate receptor (mGluR) pathway in FXS pathogenesis. The gene discussed is FMR1; the disease is fragile X syndrome.